TEVA

Teva Pharmaceutical Industries Limited $37.09 1M +1.0% 3M +7.3% YTD +19.8% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.7%
Next 1 month
-1.3%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -3.1% median, 33% of the last 43 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 74
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.05%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.70 -0.1% · Seasonal tilt -1.2%
$42.0B market cap (#525 US) $174M/day volume 40% volatility +90% 1-year -49% from ATH
52-week range · 94% of the way up · -3% from the high
$18.21$38.37

Congressional trades in TEVA Full tracker →

11 members · 6 buys / 14 sells · $104K–$510K disclosed · latest filing Jul 21, 2026.

BUY AA Alan Armstrong · traded Mar 30, 2026 $1K–$15K
BUY GG Greg Gianforte · traded Nov 13, 2020 $15K–$50K
SELL DS Donna Shalala · traded May 7, 2020 $1K–$15K
SELL DP David E. Price · traded Jun 19, 2019 $1K–$15K
SELL PM Patty Murray · traded Jun 15, 2017 $1K–$15K
SELL CB Cheri Bustos · traded Jan 30, 2017 $1K–$15K
SELL AK Angus S King · traded Oct 19, 2016 $1K–$15K
SELL KC K. Michael Conaway · traded Sep 12, 2016 $1K–$15K

Earnings Full history →

Next report 2026-11-04 (Wednesday, before open, in 51 days) · EPS est. 0.71.

1-day std dev
8.9%
Finished up
52%
Biggest pop
+28.4%
Biggest drop
-24.0%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.